Clinical Trial Update: Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)

View source ↗

Summary

A completed Belgian real-world, non-interventional study evaluating outcomes in patients with acute deep vein thrombosis treated with rivaroxaban (Xarelto).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thrombosis | Status: COMPLETED